Valuation: CSPC Innovation Pharmaceutical Co., Ltd.

Capitalization 51.53B 7.11B 6.57B 6.28B 5.51B 10.2B 611B 11.33B 71.99B 27.54B 269B 26.64B 26.11B 1,060B P/E ratio 2025 *
62.9x
P/E ratio 2026 * 47.5x
Enterprise value 46.64B 6.43B 5.95B 5.68B 4.98B 9.23B 553B 10.26B 65.16B 24.93B 243B 24.11B 23.63B 959B EV / Sales 2025 *
11.6x
EV / Sales 2026 * 8.79x
Free-Float
21.43%
Yield 2025 *
0.18%
Yield 2026 * 0.44%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.54%
Current month+5.23%
1 month+24.66%
3 months+38.11%
6 months+63.50%
Current year+39.15%
More quotes
1 week
34.08
Extreme 34.08
39.16
1 month
28.55
Extreme 28.55
40
Current year
22.02
Extreme 22.02
40
1 year
21.07
Extreme 21.07
40
3 years
5.41
Extreme 5.412
40.62
5 years
5.36
Extreme 5.3611
40.62
10 years
4.98
Extreme 4.979
40.62
More quotes
Manager TitleAgeSince
Chief Executive Officer 51 2016-06-30
Director of Finance/CFO 33 2023-04-06
Director TitleAgeSince
Chairman 56 -
Director/Board Member 62 2015-12-31
Director/Board Member 51 2015-12-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.54%0.00%+12.46%+418.62% 7.11B
-0.28%-0.05%+27.29%-24.36% 9.14B
+0.36%+4.70%+15.82%+198.86% 9.06B
-0.96%-4.43%-1.11%-10.76% 3.33B
-0.50%-3.29%-27.83%-44.30% 2.8B
-1.00%-0.47%+7.50%-52.52% 1.25B
-1.78%-6.82%+2.13%+17.92% 874M
+0.82%+4.11%+12.26%-18.85% 860M
+5.51%+4.72%-6.95%-75.19% 853M
0.00%+9.00%-28.50% - 413M
Average +0.16%+0.46%+1.31%+45.49% 3.57B
Weighted average by Cap. -0.14%+0.22%+11.31%+120.87%
See all sector performances

Financials

2025 *2026 *
Net sales 4.02B 554M 512M 490M 429M 795M 47.66B 884M 5.61B 2.15B 20.93B 2.08B 2.04B 82.61B 5.11B 705M 652M 623M 546M 1.01B 60.65B 1.12B 7.14B 2.73B 26.64B 2.64B 2.59B 105B
Net income 880M 121M 112M 107M 94.06M 174M 10.44B 194M 1.23B 471M 4.59B 455M 446M 18.1B 1.21B 167M 154M 147M 129M 239M 14.32B 266M 1.69B 645M 6.29B 624M 612M 24.83B
Net Debt -4.89B -674M -623M -596M -522M -968M -58B -1.08B -6.83B -2.61B -25.48B -2.53B -2.48B -101B -6.57B -906M -837M -800M -702M -1.3B -77.9B -1.44B -9.17B -3.51B -34.22B -3.39B -3.33B -135B
More financial data * Estimated data
Logo CSPC Innovation Pharmaceutical Co., Ltd.
CSPC Innovation Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of functional ingredients. The Company operates two segments. Functional Ingredients segment mainly provides caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, theophylline, theobromine, pentoxifylline, doxofylline, and biological enzymes. Health Food Products segment mainly provides Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, and others. The Company mainly conducts businesses within the domestic market.
Employees
2,487
More about the company
Date Price Change Volume
25-03-21 37.00 ¥ -0.54% 18,798,580
25-03-20 37.20 ¥ -2.05% 5,547,433
25-03-19 37.98 ¥ -0.18% 4,977,123
25-03-18 38.05 ¥ +1.06% 8,215,637
25-03-17 37.65 ¥ +1.76% 6,503,736

End-of-day quote Shenzhen S.E., March 20, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
37.00CNY
Average target price
41.96CNY
Spread / Average Target
+13.40%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300765 Stock